Glenmark Pharma Posts Profit of Rs 10 Cr in Q4
Business | Friday May 29, 2015
Glenmark Pharmaceuticals Ltd on Friday reported a consolidated net profit of Rs 10.61 crore for the fourth quarter that ended on March 31, 2015.
Glenmark Issues over 1 Cr Shares to Aranda, Raises Rs 945 Cr
Business | Tuesday May 19, 2015
Mauritius-based Aranda Investments is a foreign portfolio investor and a wholly-owned indirect subsidiary of Temasek Holdings (Private) Ltd, the investment arm of the Singapore government.
Glenmark Pharma Seeks Foreign Partners on Biological Drugs
Business | Thursday July 10, 2014
Glenmark Pharmaceuticals Ltd is in talks with foreign companies for a partnership on two of its biological drugs being tested for the treatment of chronic pain and autoimmune disorders, a senior executive said on Thursday.
Glenmark pulls 2,900 bottles of ulcer drug in US
Business | Friday April 18, 2014
In the last six months alone, products made by some of India's largest drugmakers, including Ranbaxy Laboratories Ltd, Sun Pharmaceutical Industries Ltd and Dr. Reddy's Laboratories Ltd have been recalled from the United States.
Glenmark's molecule for pain therapy entering human trials
Business | Thursday April 3, 2014
Glenmark has completed preclinical studies and Phase 1 enabling good laboratory practise for the molecule, GRC 27864, and has filed a Phase 1 application for first-in-human trial with the MHRA, UK, Glenmark Pharma said in a BSE filing.
Ranbaxy faces more regulatory scrutiny after US ban
Business | Thursday February 6, 2014
Ranbaxy Laboratories Ltd has been hit by more regulatory scrutiny sparked by a US ban on the bulk of its drugs, in a backlash that could bump up compliance costs and erode profitability among some Indian makers of generic drugs.
Glenmark gets board nod to merge two subsidiaries with itself
Business | Monday February 3, 2014
The merger will be effected through a court approved scheme of amalgamation, it added.
Glenmark Q3 net rises 1.56 per cent to Rs 216 crore
Business | Friday January 24, 2014
Glenmark Pharmaceuticals on Friday posted a consolidated net profit of Rs 216.23 crore for the third quarter that ended on December 31, 2013, on account of robust sales across various business verticals.
Glenmark faces patent infringement suit for cancer drug in US
Business | Tuesday December 31, 2013
The complaint has been filed against Glenmark trying to commercialise the product before the expiry of patent which is a generic version of Treanda, it added.
Glenmark gets USFDA nod for alcohol abstinence drug
Business | Monday August 12, 2013
Glenmark Generics Inc, the US-based subsidiary of Glenmark Generics Ltd (GGL), has been granted final abbreviated new drug approval (ANDA) from the United States Food and Drug Administration (USFDA) for Acamprosate Calcium Delayed Release Tablets, Glenmark Pharma said in a statement.
Glenmark Q4 net up 11 per cent at Rs 167 crore
Business | Tuesday May 7, 2013
Glenmark Pharmaceuticals on Tuesday posted a 10.93 per cent rise in its consolidated net profit at Rs 166.79 crore for its fourth quarter on the back of robust sales in both international and domestic markets.
Glenmark profit may miss estimates: StarMine
Business | Monday May 6, 2013
StarMine's SmartEstimates, which places greater emphasis on forecasts by top-rated analysts, shows Glenmark could report a net profit of Rs 156 crore for the quarter, compared with a mean consensus estimate of Rs 168 crore.
Glenmark receives US regulator nod for skin disease cream
Business | Monday January 28, 2013
Drug firm Glenmark Pharmaceuticals today said it has received US health regulator's approval to market mupirocin calcium cream, used for treating skin diseases, in the American market.
Glenmark Pharmaceuticals Ltd - Updates
Business | NDTV Correspondent | Saturday November 26, 2011
Glenmark Pharmaceuticals Ltd has informed BSE vide its letter dated June 27, 2011 that the GBR 500 deal signed by Glenmark in May'11 with Sanofi has received clearance from the Hart-Scott-Rodino Antitrust Improvements Act, USA. Following that clearance, the deal has now become effective and Glenmark has also received the first upfront payment o...
Business | NDTV Correspondent | Saturday November 26, 2011
Glenmark Generics Inc., USA, a subsidiary of Glenmarlc Generics Ltd, today announced they, have been granted final approval for’ their abbreviated new drug application (ANDA) by the United States Food and Drug Administration (U.S. FDA) for Norgestimate and Ethinyl Estradio1 tablets, USP 0.18 mg /O.035 mg, 0.215 mg/0.035 mg and 0.25/0.035 mg. Gle...
Glenmark Pharma Posts Profit of Rs 10 Cr in Q4
Business | Friday May 29, 2015
Glenmark Pharmaceuticals Ltd on Friday reported a consolidated net profit of Rs 10.61 crore for the fourth quarter that ended on March 31, 2015.
Glenmark Issues over 1 Cr Shares to Aranda, Raises Rs 945 Cr
Business | Tuesday May 19, 2015
Mauritius-based Aranda Investments is a foreign portfolio investor and a wholly-owned indirect subsidiary of Temasek Holdings (Private) Ltd, the investment arm of the Singapore government.
Glenmark Pharma Seeks Foreign Partners on Biological Drugs
Business | Thursday July 10, 2014
Glenmark Pharmaceuticals Ltd is in talks with foreign companies for a partnership on two of its biological drugs being tested for the treatment of chronic pain and autoimmune disorders, a senior executive said on Thursday.
Glenmark pulls 2,900 bottles of ulcer drug in US
Business | Friday April 18, 2014
In the last six months alone, products made by some of India's largest drugmakers, including Ranbaxy Laboratories Ltd, Sun Pharmaceutical Industries Ltd and Dr. Reddy's Laboratories Ltd have been recalled from the United States.
Glenmark's molecule for pain therapy entering human trials
Business | Thursday April 3, 2014
Glenmark has completed preclinical studies and Phase 1 enabling good laboratory practise for the molecule, GRC 27864, and has filed a Phase 1 application for first-in-human trial with the MHRA, UK, Glenmark Pharma said in a BSE filing.
Ranbaxy faces more regulatory scrutiny after US ban
Business | Thursday February 6, 2014
Ranbaxy Laboratories Ltd has been hit by more regulatory scrutiny sparked by a US ban on the bulk of its drugs, in a backlash that could bump up compliance costs and erode profitability among some Indian makers of generic drugs.
Glenmark gets board nod to merge two subsidiaries with itself
Business | Monday February 3, 2014
The merger will be effected through a court approved scheme of amalgamation, it added.
Glenmark Q3 net rises 1.56 per cent to Rs 216 crore
Business | Friday January 24, 2014
Glenmark Pharmaceuticals on Friday posted a consolidated net profit of Rs 216.23 crore for the third quarter that ended on December 31, 2013, on account of robust sales across various business verticals.
Glenmark faces patent infringement suit for cancer drug in US
Business | Tuesday December 31, 2013
The complaint has been filed against Glenmark trying to commercialise the product before the expiry of patent which is a generic version of Treanda, it added.
Glenmark gets USFDA nod for alcohol abstinence drug
Business | Monday August 12, 2013
Glenmark Generics Inc, the US-based subsidiary of Glenmark Generics Ltd (GGL), has been granted final abbreviated new drug approval (ANDA) from the United States Food and Drug Administration (USFDA) for Acamprosate Calcium Delayed Release Tablets, Glenmark Pharma said in a statement.
Glenmark Q4 net up 11 per cent at Rs 167 crore
Business | Tuesday May 7, 2013
Glenmark Pharmaceuticals on Tuesday posted a 10.93 per cent rise in its consolidated net profit at Rs 166.79 crore for its fourth quarter on the back of robust sales in both international and domestic markets.
Glenmark profit may miss estimates: StarMine
Business | Monday May 6, 2013
StarMine's SmartEstimates, which places greater emphasis on forecasts by top-rated analysts, shows Glenmark could report a net profit of Rs 156 crore for the quarter, compared with a mean consensus estimate of Rs 168 crore.
Glenmark receives US regulator nod for skin disease cream
Business | Monday January 28, 2013
Drug firm Glenmark Pharmaceuticals today said it has received US health regulator's approval to market mupirocin calcium cream, used for treating skin diseases, in the American market.
Glenmark Pharmaceuticals Ltd - Updates
Business | NDTV Correspondent | Saturday November 26, 2011
Glenmark Pharmaceuticals Ltd has informed BSE vide its letter dated June 27, 2011 that the GBR 500 deal signed by Glenmark in May'11 with Sanofi has received clearance from the Hart-Scott-Rodino Antitrust Improvements Act, USA. Following that clearance, the deal has now become effective and Glenmark has also received the first upfront payment o...
Business | NDTV Correspondent | Saturday November 26, 2011
Glenmark Generics Inc., USA, a subsidiary of Glenmarlc Generics Ltd, today announced they, have been granted final approval for’ their abbreviated new drug application (ANDA) by the United States Food and Drug Administration (U.S. FDA) for Norgestimate and Ethinyl Estradio1 tablets, USP 0.18 mg /O.035 mg, 0.215 mg/0.035 mg and 0.25/0.035 mg. Gle...
................................ Advertisement ................................
................................ Advertisement ................................
